{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:37:40Z","timestamp":1782934660582,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10875-016-0316-z","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T08:51:03Z","timestamp":1469004663000},"page":"713-724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency"],"prefix":"10.1007","volume":"36","author":[{"given":"Geoffrey D. E.","family":"Cuvelier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar S.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna A.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlis L.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,20]]},"reference":[{"issue":"10","key":"316_CR1","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.4049\/jimmunol.152.10.4758","volume":"152","author":"AC Chan","year":"1994","unstructured":"Chan AC, van Oers NS, Tran A, Turka L, Law CL, Ryan JC, et al. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol. 1994;152(10):4758\u201366.","journal-title":"J Immunol"},{"issue":"1","key":"316_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1600-065X.2008.00753.x","volume":"228","author":"BB Au-Yeung","year":"2009","unstructured":"Au-Yeung BB, Deindl S, Hsu LY, Palacios EH, Levin SE, Kuriyan J, et al. The structure, regulation, and function of ZAP-70. Immunol Rev. 2009;228(1):41\u201357. doi:10.1111\/j.1600-065X.2008.00753.x.","journal-title":"Immunol Rev"},{"issue":"5","key":"316_CR3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/0092-8674(94)90368-9","volume":"76","author":"E Arpaia","year":"1994","unstructured":"Arpaia E, Shahar M, Dadi H, Cohen A, Roifman CM. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell. 1994;76(5):947\u201358.","journal-title":"Cell"},{"issue":"6","key":"316_CR4","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1084\/jem.170.6.2177","volume":"170","author":"CM Roifman","year":"1989","unstructured":"Roifman CM, Hummel D, Martinez-Valdez H, Thorner P, Doherty PJ, Pan S, et al. Depletion of CD8+ cells in human thymic medulla results in selective immune deficiency. J Exp Med. 1989;170(6):2177\u201382.","journal-title":"J Exp Med"},{"issue":"3","key":"316_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1365-2249.1992.tb05856.x","volume":"90","author":"WJ Monafo","year":"1992","unstructured":"Monafo WJ, Polmar SH, Neudorf S, Mather A, Filipovich AH. A hereditary immunodeficiency characterized by CD8+ T lymphocyte deficiency and impaired lymphocyte activation. Clin Exp Immunol. 1992;90(3):390\u20133.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"316_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.20150888","volume":"213","author":"AY Chan","year":"2016","unstructured":"Chan AY, Punwani D, Kadlecek TA, Cowan MJ, Olson JL, Mathes EF, et al. A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J Exp Med. 2016;213(2):155\u201365. doi:10.1084\/jem.20150888.","journal-title":"J Exp Med"},{"issue":"1","key":"316_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00431-008-0718-x","volume":"168","author":"T Turul","year":"2009","unstructured":"Turul T, Tezcan I, Artac H, de Bruin-Versteeg S, Barendregt BH, Reisli I, et al. Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency. Eur J Pediatr. 2009;168(1):87\u201393. doi:10.1007\/s00431-008-0718-x.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"316_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jaci.2010.09.016","volume":"127","author":"A Newell","year":"2011","unstructured":"Newell A, Dadi H, Goldberg R, Ngan BY, Grunebaum E, Roifman CM. Diffuse large B-cell lymphoma as presenting feature of Zap-70 deficiency. J Allergy Clin Immunol. 2011;127(2):517\u201320. doi:10.1016\/j.jaci.2010.09.016.","journal-title":"J Allergy Clin Immunol"},{"issue":"5165","key":"316_CR9","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1126\/science.8202712","volume":"264","author":"ME Elder","year":"1994","unstructured":"Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, et al. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science. 1994;264(5165):1596\u20139.","journal-title":"Science"},{"issue":"2","key":"316_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1006\/clin.1997.4365","volume":"84","author":"B Mazer","year":"1997","unstructured":"Mazer B, Harbeck RJ, Franklin R, Schwinzer R, Kubo R, Hayward A, et al. Phenotypic features of selective T cell deficiency characterized by absence of CD8+ T lymphocytes and undetectable mRNA for ZAP-70 kinase. Clin Immunol Immunopathol. 1997;84(2):129\u201338.","journal-title":"Clin Immunol Immunopathol"},{"issue":"5165","key":"316_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1126\/science.8202713","volume":"264","author":"AC Chan","year":"1994","unstructured":"Chan AC, Kadlecek TA, Elder ME, Filipovich AH, Kuo WL, Iwashima M, et al. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science. 1994;264(5165):1599\u2013601.","journal-title":"Science"},{"issue":"4","key":"316_CR12","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.jaci.2012.09.020","volume":"131","author":"VH Kim","year":"2013","unstructured":"Kim VH, Murguia L, Schechter T, Grunebaum E, Roifman CM. Emergency treatment for zeta chain-associated protein of 70 kDa (ZAP70) deficiency. J Allergy Clin Immunol. 2013;131(4):1233\u20135. doi:10.1016\/j.jaci.2012.09.020.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"316_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.clim.2015.03.014","volume":"158","author":"HH Akar","year":"2015","unstructured":"Akar HH, Patiroglu T, Akyildiz BN, Tekerek NU, Dogan MS, Doganay S, et al. Silent brain infarcts in two patients with zeta chain-associated protein 70 kDa (ZAP70) deficiency. Clin Immunol. 2015;158(1):88\u201391. doi:10.1016\/j.clim.2015.03.014.","journal-title":"Clin Immunol"},{"issue":"2","key":"316_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10875-015-0229-2","volume":"36","author":"S Esenboga","year":"2016","unstructured":"Esenboga S, Ayvaz DC, Cetinkaya PG, van der Burg M, Tezcan I. An infant with ZAP-70 deficiency with disseminated mycobacterial disease. J Clin Immunol. 2016;36(2):103\u20136. doi:10.1007\/s10875-015-0229-2.","journal-title":"J Clin Immunol"},{"issue":"2","key":"316_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clim.2015.07.002","volume":"161","author":"F Hauck","year":"2015","unstructured":"Hauck F, Blumenthal B, Fuchs S, Lenoir C, Martin E, Speckmann C, et al. SYK expression endows human ZAP70-deficient CD8 T cells with residual TCR signaling. Clin Immunol. 2015;161(2):103\u20139. doi:10.1016\/j.clim.2015.07.002.","journal-title":"Clin Immunol"},{"issue":"2","key":"316_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.gene.2012.10.062","volume":"512","author":"E Karaca","year":"2013","unstructured":"Karaca E, Karakoc-Aydiner E, Bayrak OF, Keles S, Sevli S, Barlan IB, et al. Identification of a novel mutation in ZAP70 and prenatal diagnosis in a Turkish family with severe combined immunodeficiency disorder. Gene. 2013;512(2):189\u201393. doi:10.1016\/j.gene.2012.10.062.","journal-title":"Gene"},{"issue":"1","key":"316_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1046\/j.1365-2249.1999.00759.x","volume":"115","author":"K Katamura","year":"1999","unstructured":"Katamura K, Tai G, Tachibana T, Yamabe H, Ohmori K, Mayumi M, et al. Existence of activated and memory CD4+ T cells in peripheral blood and their skin infiltration in CD8 deficiency. Clin Exp Immunol. 1999;115(1):124\u201330.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"316_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1046\/j.1365-2567.2001.01246.x","volume":"103","author":"S Toyabe","year":"2001","unstructured":"Toyabe S, Watanabe A, Harada W, Karasawa T, Uchiyama M. Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling. Immunology. 2001;103(2):164\u201371.","journal-title":"Immunology"},{"issue":"1","key":"316_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4049\/jimmunol.166.1.656","volume":"166","author":"ME Elder","year":"2001","unstructured":"Elder ME, Skoda-Smith S, Kadlecek TA, Wang F, Wu J, Weiss A. Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70. J Immunol. 2001;166(1):656\u201361.","journal-title":"J Immunol"},{"issue":"7","key":"316_CR20","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/eji.200939385","volume":"39","author":"C Picard","year":"2009","unstructured":"Picard C, Dogniaux S, Chemin K, Maciorowski Z, Lim A, Mazerolles F, et al. Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity. Eur J Immunol. 2009;39(7):1966\u201376. doi:10.1002\/eji.200939385.","journal-title":"Eur J Immunol"},{"issue":"7","key":"316_CR21","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.4049\/jimmunol.165.7.3578","volume":"165","author":"E Meinl","year":"2000","unstructured":"Meinl E, Lengenfelder D, Blank N, Pirzer R, Barata L, Hivroz C. Differential requirement of ZAP-70 for CD2-mediated activation pathways of mature human T cells. J Immunol. 2000;165(7):3578\u201383.","journal-title":"J Immunol"},{"issue":"21","key":"316_CR22","doi-asserted-by":"publisher","first-page":"15832","DOI":"10.1074\/jbc.M908568199","volume":"275","author":"N Noraz","year":"2000","unstructured":"Noraz N, Schwarz K, Steinberg M, Dardalhon V, Rebouissou C, Hipskind R, et al. Alternative antigen receptor (TCR) signaling in T cells derived from ZAP-70-deficient patients expressing high levels of Syk. J Biol Chem. 2000;275(21):15832\u20138. doi:10.1074\/jbc.M908568199.","journal-title":"J Biol Chem"},{"issue":"2","key":"316_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/bmt.2011.71","volume":"47","author":"M Honig","year":"2012","unstructured":"Honig M, Schuetz C, Schwarz K, Rojewski M, Jacobsen E, Lahr G, et al. Immunological reconstitution in a patient with ZAP-70 deficiency following transfusion of blood lymphocytes from a previously transplanted sibling without conditioning. Bone Marrow Transplant. 2012;47(2):305\u20137. doi:10.1038\/bmt.2011.71.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"316_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.bmt.1703800","volume":"31","author":"F Fagioli","year":"2003","unstructured":"Fagioli F, Biasin E, Berger M, Nesi F, Saroglia EH, Miniero R, et al. Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome. Bone Marrow Transplant. 2003;31(2):133\u20136. doi:10.1038\/sj.bmt.1703800.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"316_CR25","first-page":"413","volume":"14","author":"LT Barata","year":"2001","unstructured":"Barata LT, Henriques R, Hivroz C, Jouanguy E, Paiva A, Freitas AM, et al. Primary immunodeficiency secondary to ZAP-70 deficiency. Acta Med Port. 2001;14(4):413\u20137.","journal-title":"Acta Med Port"},{"issue":"1","key":"316_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clim.2014.04.015","volume":"153","author":"S Grazioli","year":"2014","unstructured":"Grazioli S, Bennett M, Hildebrand KJ, Vallance H, Turvey SE, Junker AK. Limitation of TREC-based newborn screening for ZAP70 severe combined immunodeficiency. Clin Immunol. 2014;153(1):209\u201310. doi:10.1016\/j.clim.2014.04.015.","journal-title":"Clin Immunol"},{"issue":"5","key":"316_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/jama.295.5.508","volume":"295","author":"E Grunebaum","year":"2006","unstructured":"Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006;295(5):508\u201318. doi:10.1001\/jama.295.5.508.","journal-title":"JAMA"},{"issue":"6","key":"316_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bmt.1702215","volume":"25","author":"I Dalal","year":"2000","unstructured":"Dalal I, Reid B, Doyle J, Freedman M, Calderwood S, Saunders F, et al. Matched unrelated bone marrow transplantation for combined immunodeficiency. Bone Marrow Transplant. 2000;25(6):613\u201321. doi:10.1038\/sj.bmt.1702215.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"316_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1401177","volume":"371","author":"SY Pai","year":"2014","unstructured":"Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000\u20132009. N Engl J Med. 2014;371(5):434\u201346. doi:10.1056\/NEJMoa1401177.","journal-title":"N Engl J Med"},{"issue":"7","key":"316_CR30","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s10875-013-9917-y","volume":"33","author":"CC Dvorak","year":"2013","unstructured":"Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. J Clin Immunol. 2013;33(7):1156\u201364. doi:10.1007\/s10875-013-9917-y.","journal-title":"J Clin Immunol"},{"issue":"4","key":"316_CR31","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","volume":"133","author":"WT Shearer","year":"2014","unstructured":"Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, et al. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol. 2014;133(4):1092\u20138. doi:10.1016\/j.jaci.2013.09.044.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"316_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clim.2011.05.007","volume":"141","author":"K Felgentreff","year":"2011","unstructured":"Felgentreff K, Perez-Becker R, Speckmann C, Schwarz K, Kalwak K, Markelj G, et al. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol. 2011;141(1):73\u201382. doi:10.1016\/j.clim.2011.05.007.","journal-title":"Clin Immunol"},{"key":"316_CR33","volume-title":"Pediatric reference intervals","author":"SJ Soldin","year":"2007","unstructured":"Soldin SJ, Brugnara C, Wong EC. Pediatric reference intervals. Sixthth ed. Washington: American Association for Clinical Chemistry Press; 2007.","edition":"Sixth"},{"issue":"5","key":"316_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","volume":"112","author":"WT Shearer","year":"2003","unstructured":"Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112(5):973\u201380. doi:10.1016\/j.jaci.2003.07.003.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"316_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.clim.2009.05.020","volume":"133","author":"R van Gent","year":"2009","unstructured":"van Gent R, van Tilburg CM, Nibbelke EE, Otto SA, Gaiser JF, Janssens-Korpela PL, et al. Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin Immunol. 2009;133(1):95\u2013107. doi:10.1016\/j.clim.2009.05.020.","journal-title":"Clin Immunol"},{"issue":"1","key":"316_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaci.2012.04.029","volume":"130","author":"CM Roifman","year":"2012","unstructured":"Roifman CM, Somech R, Kavadas F, Pires L, Nahum A, Dalal I, et al. Defining combined immunodeficiency. J Allergy Clin Immunol. 2012;130(1):177\u201383. doi:10.1016\/j.jaci.2012.04.029.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"316_CR37","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1084\/jem.165.4.1212","volume":"165","author":"WJ Murphy","year":"1987","unstructured":"Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med. 1987;165(4):1212\u20137.","journal-title":"J Exp Med"},{"issue":"4","key":"316_CR38","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jaci.2013.01.047","volume":"131","author":"E Haddad","year":"2013","unstructured":"Haddad E, Leroy S, Buckley RH. B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? J Allergy Clin Immunol. 2013;131(4):994\u20131000. doi:10.1016\/j.jaci.2013.01.047.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"316_CR39","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jaci.2014.06.021","volume":"134","author":"CC Dvorak","year":"2014","unstructured":"Dvorak CC, Hassan A, Slatter MA, Honig M, Lankester AC, Buckley RH, et al. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. J Allergy Clin Immunol. 2014;134(4):935\u201343. doi:10.1016\/j.jaci.2014.06.021. e15.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"316_CR40","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaci.2010.02.012","volume":"125","author":"RH Buckley","year":"2010","unstructured":"Buckley RH. B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review. J Allergy Clin Immunol. 2010;125(4):790\u20137. doi:10.1016\/j.jaci.2010.02.012.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"316_CR41","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1056\/NEJM199902183400703","volume":"340","author":"RH Buckley","year":"1999","unstructured":"Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340(7):508\u201316. doi:10.1056\/NEJM199902183400703.","journal-title":"N Engl J Med"},{"issue":"1","key":"316_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-012-9797-6","volume":"33","author":"RH Buckley","year":"2013","unstructured":"Buckley RH, Win CM, Moser BK, Parrott RE, Sajaroff E, Sarzotti-Kelsoe M. Post-transplantation B cell function in different molecular types of SCID. J Clin Immunol. 2013;33(1):96\u2013110. doi:10.1007\/s10875-012-9797-6.","journal-title":"J Clin Immunol"},{"key":"316_CR43","doi-asserted-by":"crossref","unstructured":"Brager R, Haynes A, Grunenbaum E, Hoenig M, Al-Mousa H, Al-Herz W et al. Presentation and outcome of Zap 70 deficiency [Abstract]. Biol Blood Marrow Transplant. [Abstract]. In press 2015.","DOI":"10.1016\/j.bbmt.2014.11.434"},{"key":"316_CR44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ymgmr.2014.07.003","volume":"1","author":"O Jilkina","year":"2014","unstructured":"Jilkina O, Thompson JR, Kwan L, Van Caeseele P, Rockman-Greenberg C, Schroeder ML. Retrospective TREC testing of newborns with severe combined immunodeficiency and other primary immunodeficiency disorders. Mol Genet Metab Reports. 2014;1:324\u201333.","journal-title":"Mol Genet Metab Reports"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-016-0316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-016-0316-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-016-0316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T08:21:10Z","timestamp":1692433270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-016-0316-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,20]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1007\/s10875-016-0316-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,20]]},"assertion":[{"value":"18 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This project was approved by the Health Research Ethics Board at the University of Manitoba. As a retrospective study, formal consent of participants was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}